Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Alopecia areata involves immune response and gene changes affecting hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Hair loss can be caused by stress, aging, and harmful substances that create an imbalance in the body's natural processes.

Nerves and chemicals in the body can affect hair growth and loss.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Arachidonic acid helps hair grow by increasing growth factors and improving follicle health.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.